Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9758 |
High Similarity |
NPD7251 |
Discontinued |
0.9699 |
High Similarity |
NPD7808 |
Phase 3 |
0.9697 |
High Similarity |
NPD6797 |
Phase 2 |
0.9636 |
High Similarity |
NPD7472 |
Approved |
0.9581 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.9576 |
High Similarity |
NPD7054 |
Approved |
0.9401 |
High Similarity |
NPD7074 |
Phase 3 |
0.9112 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.9053 |
High Similarity |
NPD3818 |
Discontinued |
0.9048 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.9048 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.9048 |
High Similarity |
NPD6166 |
Phase 2 |
0.8848 |
High Similarity |
NPD2801 |
Approved |
0.8802 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8683 |
High Similarity |
NPD3817 |
Phase 2 |
0.8675 |
High Similarity |
NPD1934 |
Approved |
0.8631 |
High Similarity |
NPD3882 |
Suspended |
0.8512 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8466 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8462 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8424 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8363 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8306 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8304 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8303 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8266 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8225 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8187 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8129 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8111 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8107 |
Intermediate Similarity |
NPD1653 |
Approved |
0.809 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.8068 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.8047 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8036 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7989 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7976 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7944 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7929 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7923 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7923 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7912 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7903 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7876 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7874 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7838 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7833 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7831 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7831 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7829 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7812 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7812 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7812 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7812 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7812 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7812 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7812 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7809 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7809 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7784 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7784 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7784 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7784 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7771 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7765 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7722 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7716 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7701 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7677 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7665 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7657 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7653 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7653 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7647 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7638 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7638 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.763 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7622 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7619 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7617 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7617 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7616 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7611 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7605 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.76 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.76 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7598 |
Intermediate Similarity |
NPD919 |
Approved |
0.7598 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7571 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7552 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7552 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7527 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7514 |
Intermediate Similarity |
NPD37 |
Approved |
0.7512 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7487 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7486 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7486 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7486 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7486 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.747 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.747 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7462 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7387 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7387 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7385 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD943 |
Approved |
0.7365 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7356 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.733 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.733 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7321 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7321 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7293 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7289 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7283 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7278 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7273 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7253 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7251 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7246 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7229 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7222 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7193 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7186 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7184 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7169 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7164 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7151 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7123 |
Intermediate Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.7119 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7119 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7119 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7112 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7101 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7059 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7056 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7039 |
Intermediate Similarity |
NPD920 |
Approved |
0.7029 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7029 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7029 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7016 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.701 |
Intermediate Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.6994 |
Remote Similarity |
NPD3748 |
Approved |
0.6964 |
Remote Similarity |
NPD9494 |
Approved |
0.6961 |
Remote Similarity |
NPD3226 |
Approved |
0.6957 |
Remote Similarity |
NPD5353 |
Approved |
0.6954 |
Remote Similarity |
NPD6099 |
Approved |
0.6954 |
Remote Similarity |
NPD6100 |
Approved |
0.6943 |
Remote Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.6941 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6935 |
Remote Similarity |
NPD4363 |
Phase 3 |
0.6935 |
Remote Similarity |
NPD4360 |
Phase 2 |
0.6927 |
Remote Similarity |
NPD642 |
Clinical (unspecified phase) |
0.6927 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6919 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6909 |
Remote Similarity |
NPD1091 |
Approved |
0.6897 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6879 |
Remote Similarity |
NPD6651 |
Approved |
0.6872 |
Remote Similarity |
NPD7390 |
Discontinued |
0.6869 |
Remote Similarity |
NPD7907 |
Approved |
0.6866 |
Remote Similarity |
NPD8058 |
Clinical (unspecified phase) |
0.6866 |
Remote Similarity |
NPD8059 |
Phase 3 |
0.6856 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6842 |
Remote Similarity |
NPD2313 |
Discontinued |
0.6836 |
Remote Similarity |
NPD1243 |
Approved |
0.6836 |
Remote Similarity |
NPD1652 |
Phase 2 |
0.6826 |
Remote Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.6824 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6818 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6818 |
Remote Similarity |
NPD2344 |
Approved |
0.6816 |
Remote Similarity |
NPD643 |
Clinical (unspecified phase) |
0.6805 |
Remote Similarity |
NPD2798 |
Approved |
0.68 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6798 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6793 |
Remote Similarity |
NPD6386 |
Approved |
0.6793 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6793 |
Remote Similarity |
NPD6385 |
Approved |
0.6789 |
Remote Similarity |
NPD5242 |
Approved |
0.6786 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.678 |
Remote Similarity |
NPD5006 |
Approved |
0.678 |
Remote Similarity |
NPD5005 |
Approved |
0.6772 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6771 |
Remote Similarity |
NPD2163 |
Approved |
0.6768 |
Remote Similarity |
NPD6842 |
Approved |
0.6768 |
Remote Similarity |
NPD6841 |
Approved |
0.6768 |
Remote Similarity |
NPD6843 |
Phase 3 |
0.6754 |
Remote Similarity |
NPD2403 |
Approved |
0.6746 |
Remote Similarity |
NPD1203 |
Approved |
0.6745 |
Remote Similarity |
NPD7930 |
Approved |
0.6744
|
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |